SciFi Futures
← Concepts
Neurotechnology

Cyborg body augmentation

Elective surgical upgrades that make the body partly machine, with implanted eyes that outperform natural ones, wired-in reflexes, built-in weapons and replaceable organs, bought in clinics like any other product.

In shortCyborg body augmentation, from Neuromancer (William Gibson, 1984), is at technology readiness level 1 of 9 (basic principles observed) at its weakest link. Held back by Electronic reflex acceleration. Science status: consistent with known physics; key effects unproven at scale. Estimated new funding to unlock: $5.3B–25B (a floor; some parts are priced only to early research).

Molly's mirrored lenses are surgically inset over her eye sockets, four-centimeter scalpel blades slide out from under her fingernails, and her reflexes are wired; Case gets a new pancreas and liver and his damaged nervous system rebuilt in a Chiba clinic.
Neuromancer by William Gibson, 1984Set in 2035Not by then9 years left to climb 7 TRL steps (1.3 yrs/step)

Closest todayThe PRIMA subretinal implant restored letter reading to people blinded by macular degeneration (NEJM, 2026); bone-anchored, nerve-controlled bionic arms and legs are used daily by amputees.

Dependency stack

Research TRL 1–3Development TRL 4–6Deployment TRL 7–9
Sort by
  • Wired reflexes that make a street samurai faster than any unmodified human
    • Reaction time is dominated by sensory processing and decision-making, which an implant cannot skip without acting for the person
    • Reading intent fast and reliably enough to beat natural motor pathways
    • Muscles and tendons limit speed even when triggered early
    plausibleTRL 1
    • Reading motor intent at millisecond resolution
      ✕2 blockers›
      • Tissue response degrades signal over years
      • Channel count and wireless bandwidth
      TRL 6
      • Channel count is limited by wireless data and power budget
        ✕3 blockers›
        • Tissue heating caps implant power at a few hundred milliwatts, which bounds radio and compute
        • Raw broadband neural data exceeds the link, forcing on-implant spike detection and compression
        • Battery or wireless-power lifetime versus the decades a permanent interface implies
        TRL 5
        • Implant power density sets what telemetry and on-board compute are affordable
          ✕2 blockers›
          • Cycle life of lithium-metal anodes
          • Thermal runaway safety
          TRL 6
  • Molly's lenses replace her eyes and add readouts and low-light vision
    ✕3 blockers›
    • Pixel density and field of view far below the natural retina
    • Implants only work while some retinal or cortical circuitry survives
    • Encoding color and natural percepts rather than flashes of light
    TRL 3
  • Compact actuators to extend and retract implanted mechanisms
    ✕3 blockers›
    • Kilovolt supply electronics and dielectric breakdown risk
    • Low force per actuator and limited cycle life versus electric motors
    • No integrated sensing comparable to muscle spindles
    TRL 4
  • Implants that keep working with nerves for decades rather than scarring over
    ✕3 blockers›
    • Micromotion between rigid device and pulsating tissue drives chronic inflammation
    • Thin-film encapsulation (polyimide, parylene, SiC) eventually admits water and fails
    • Electrode charge-injection limits and corrosion under years of continuous stimulation
    TRL 4
  • Hardware anchored in bone and driven by the wearer's own nerves, like Molly's retractable blades
    ✕3 blockers›
    • Infection risk where the implant passes through the skin
    • Durable implanted electrodes for decades of use
    • Natural-feeling touch and position feedback
    TRL 7
  • Off-the-shelf replacement organs like Case's new pancreas and liver
    ✕4 blockers›
    • Graft survival measured in months, not years - chronic rejection and thrombotic microangiopathy persist
    • Porcine endogenous retrovirus and novel-zoonosis risk requires lifelong recipient surveillance
    • Organ growth mismatch and porcine protein incompatibilities (complement, coagulation) are only partly corrected by current edit sets
    • Designated-pathogen-free breeding and organ-recovery facilities do not exist at transplant-program scale
    TRL 6
    • Edited cell lines are turned into animals by cloning
      ✕3 blockers›
      • Incomplete epigenetic reprogramming of the donor nucleus produces placental defects and large-offspring syndrome
      • Efficiency is a few percent of transferred embryos, so each live birth consumes many donor eggs and surrogates
      • Donor egg supply is the limiting input for any primate-scale program
      TRL 5
    • Even heavily edited organs are rejected without durable tolerance
      ✕3 blockers›
      • Chronic antibody-mediated rejection proceeds even under current immunosuppression
      • Tolerance protocols trade rejection risk for conditioning toxicity and graft-versus-host disease
      • No assay predicts which recipients can be safely weaned off drugs
      TRL 5
    • Donor lines need tens of simultaneous edits across rejection, coagulation and retroviral loci
      ✕3 blockers›
      • Structural variants and large deletions accumulate with edit count and are missed by short-read screening
      • Edited cell lines lose clonogenic and developmental potency after many rounds of editing
      • No method reaches the thousands of edits implied by whole-genome rewriting
      TRL 6
      • Higher-fidelity, smaller editor and recombinase proteins are the route to many simultaneous edits
        ✕1 blocker›
        • Designing catalysis and conformational dynamics
        TRL 6

Who could unlock it

Electronic reflex accelerationTRL 1bottleneck
  • Grégoire CourtineResearcher, EPFL
    Leads closed-loop spinal cord stimulation that turns decoded intent into walking after paralysis
  • ONWARD MedicalCompany
    Commercializing spinal cord stimulation therapies developed with EPFL
Implanted visual prosthesesTRL 3
  • Science CorporationStartup
    Acquired and took the PRIMA subretinal implant through its pivotal trial and regulatory filing
  • Daniel PalankerResearcher, Stanford University
    Invented the photovoltaic subretinal implant technology behind PRIMA
Artificial muscle actuatorsTRL 4
  • Christoph KeplingerResearcher, Max Planck Institute for Intelligent Systems
    Principal inventor of HASEL electrohydraulic artificial muscles; leads the Robotic Materials department
  • Artimus RoboticsStartup
    CU Boulder spinout (2018) commercializing HASEL actuators, funded by NSF SBIR and other grants
  • Clone RoboticsStartup
    Unveiled Protoclone (Feb 2025), a musculoskeletal android driven by 1,000+ hydraulic 'Myofiber' artificial muscles
  • Ray BaughmanResearcher, University of Texas at Dallas NanoTech Institute
    Pioneered twisted and coiled carbon-nanotube and polymer-fiber artificial muscles
Glial-scar-free chronic neural implant materialsTRL 4
  • Jia LiuResearcher, Harvard SEAS
    Pioneer of tissue-like and syringe-injectable mesh electronics; co-founded Axoft
  • AxoftStartup
    Soft Fleuron polymer probe completed a first-in-human safety study in 2025; raised over $18M
  • ParadromicsStartup
    Reported four years of stable preclinical recording in 2026 with platinum-iridium microwires and a titanium hermetic package
  • NeuralinkStartup
    Thin polymer thread electrodes implanted in multiple human participants since 2024
Nerve-controlled bone-anchored bionic limbsTRL 7
  • IntegrumCompany
    Makes the OPRA bone-anchored implant system for prosthetic limbs
  • Max Ortiz CatalanResearcher
    Led the self-contained neuromusculoskeletal arm prosthesis used daily by amputees
  • Hugh HerrAcademic lab, MIT Media Lab Biomechatronics group
    Developed the agonist-antagonist myoneural interface and the neurally controlled bionic leg

Beyond engineering

  • Medical ethics of surgery on healthy bodies for enhancement rather than therapy
  • Device makers abandoning implants, leaving users with unsupported hardware in their bodies
  • Weapons law for blades and other implanted arms